These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3666266)

  • 21. Long-term use of oral contraceptives and risk of invasive cervical cancer.
    Brinton LA; Huggins GR; Lehman HF; Mallin K; Savitz DA; Trapido E; Rosenthal J; Hoover R
    Int J Cancer; 1986 Sep; 38(3):339-44. PubMed ID: 3744592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Squamous and adenocarcinoma of the uterine cervix: a comparison using routine data.
    Silcocks PB; Thornton-Jones H; Murphy M
    Br J Cancer; 1987 Mar; 55(3):321-5. PubMed ID: 3567065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Morphofunctional features of the cervix uteri in women using hormonal contraception].
    Prilepskaia VN; Kondrikov NI; Nazarova NM
    Akush Ginekol (Mosk); 1991 Dec; (12):6-10. PubMed ID: 1789353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: a clinicopathological study of 24 cases.
    Jones MW; Silverberg SG; Kurman RJ
    Int J Gynecol Pathol; 1993 Jan; 12(1):1-7. PubMed ID: 8418074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study.
    Vessey M; Yeates D
    Contraception; 2013 Dec; 88(6):678-83. PubMed ID: 24090961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.
    Sperling MA
    West J Med; 1975 Jan; 122(1):42-9. PubMed ID: 1089006
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies.
    International Collaboration of Epidemiological Studies of Cervical Cancer
    Int J Cancer; 2007 Feb; 120(4):885-91. PubMed ID: 17131323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County.
    Peters RK; Chao A; Mack TM; Thomas D; Bernstein L; Henderson BE
    J Natl Cancer Inst; 1986 Mar; 76(3):423-8. PubMed ID: 3456460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark. III. Role of oral contraceptive use.
    Kjaer SK; Engholm G; Dahl C; Bock JE; Lynge E; Jensen OM
    Cancer Causes Control; 1993 Nov; 4(6):513-9. PubMed ID: 8280828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The contraceptive polyp: a diagnostic dilemma.
    Anderson WR; Levine AJ
    J Iowa Med Soc; 1968 Jun; 58(6):585-8. PubMed ID: 5650112
    [No Abstract]   [Full Text] [Related]  

  • 31. HPV types and cofactors causing cervical cancer in Peru.
    Santos C; Muñoz N; Klug S; Almonte M; Guerrero I; Alvarez M; Velarde C; Galdos O; Castillo M; Walboomers J; Meijer C; Caceres E
    Br J Cancer; 2001 Sep; 85(7):966-71. PubMed ID: 11592767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral contraceptives and gynecologic cancer: an update for the 1990s.
    Kaunitz AM
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiology and clinical aspects of adenomatous and squamous epithelial cancers of the uterine cervix].
    Naumann C; Geissler U; Sarembe B
    Zentralbl Gynakol; 1989; 111(5):317-23. PubMed ID: 2786300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocervical neoplasia in long-term users of oral contraceptives: clinical and pathologic observations.
    Valente PT; Hanjani P
    Obstet Gynecol; 1986 May; 67(5):695-704. PubMed ID: 3960441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic gestagens and endocervical adenocarcinoma.
    Dallenbach-Hellweg G
    Int J Gynecol Pathol; 1984; 3(2):241. PubMed ID: 6490316
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral contraceptive steroids and dysplasia and carcinoma of the cervix uteri.
    Diddle AW; Gardner WH; Williamson PJ; Johnson JR; Hemphill JL; Godwin CW
    J Tenn Med Assoc; 1978 Oct; 71(10):725-7, 740. PubMed ID: 723247
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk factors for adenocarcinoma of the cervix: a case-control study.
    Parazzini F; La Vecchia C; Negri E; Fasoli M; Cecchetti G
    Br J Cancer; 1988 Feb; 57(2):201-4. PubMed ID: 3358912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral contraceptives and cancer.
    Edgren RA
    Int J Fertil; 1991; 36 Suppl 3():37-50. PubMed ID: 1687403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive adenocarcinoma of the uterine cervix.
    Gallup DG; Abell MR
    Obstet Gynecol; 1977 May; 49(5):596-603. PubMed ID: 850577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinoma of the cervix in oral contraceptive steroid and IUD users and nonusers.
    Sandmire HF; Austin SD; Bechtel RC
    Am J Obstet Gynecol; 1976 Jun; 125(3):339-45. PubMed ID: 1275024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.